Trading Statement
RH BOPHELO LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2016/533398/06)
(JSE & RSE Share Code: RHB, ISIN: ZAE000244737)
(“RH Bophelo” or “the Company”)
Trading Statement
The Company is in the process of finalising its financial year results for the year ended 29 February 2020, which
are scheduled to be released on or about 31 July 2020.
Shareholders are advised that the Company expects to report earnings per share and headline per share of
between 126 to 134 cents, being an increase of between 200% and 219%, compared to prior year of 42 cents
per share.
The above is based on the weighted average number of shares in issue during the year ended 29 February
2020 of 53 592 090 (prior year period: 50 938 356). As at 29 February 2020, the Company had a total of
55 934 179 (prior year: 51 250 000) shares in issue, of which 2 500 000 shares were issued in the current year
as part of Africa Healthcare acquisition and Medicare Private hospital.
The financial information on which this trading statement has been based has neither been reviewed nor
reported on by the Company’s external auditors.
Johannesburg
30 July 2020
Sponsor: Deloitte & Touche Sponsor Services Proprietary Limited
Date: 30-07-2020 11:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.